Optimizing antihypertensive therapy in patients with diabetes mellitus

Hypertens Res. 2023 Mar;46(3):797-800. doi: 10.1038/s41440-022-01150-5. Epub 2022 Dec 28.

Authors

Wenhao Liu¹, Yasutomi Higashikuni², Masataka Sata³

Affiliations

¹ Department of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
² Department of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. yasutomihigashikuni@g.ecc.u-tokyo.ac.jp.
³ Department of Cardiovascular Medicine, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima-shi, Tokushima, 770-8503, Japan.

PMID: 36577847
DOI: 10.1038/s41440-022-01150-5

No abstract available

Keywords: Antihypertensive agents; Diabetes mellitus; Hypertension; Inflammation; Physiopathology.

Publication types

Editorial
Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antihypertensive Agents / therapeutic use
Blood Pressure / physiology
Diabetes Mellitus*
Humans
Hypertension* / physiopathology

Substances

Antihypertensive Agents
Angiotensin-Converting Enzyme Inhibitors